Erythromycin resistance by ribosome modification.
作者信息
Weisblum B
机构信息
Department of Pharmacology, University of Wisconsin Medical School, Madison 53706, USA.
出版信息
Antimicrob Agents Chemother. 1995 Mar;39(3):577-85. doi: 10.1128/AAC.39.3.577.
Abstract
摘要
相似文献
1
Erythromycin resistance by ribosome modification.通过核糖体修饰产生的红霉素耐药性。
Antimicrob Agents Chemother. 1995 Mar;39(3):577-85. doi: 10.1128/AAC.39.3.577.
2
3
Erythromycin inhibition of 50S ribosomal subunit formation in Escherichia coli cells.红霉素对大肠杆菌细胞中50S核糖体亚基形成的抑制作用。
Mol Microbiol. 2001 May;40(4):951-62. doi: 10.1046/j.1365-2958.2001.02438.x.
4
Alteration of 23 S ribosomal RNA and erythromycin-induced resistance to lincomycin and spiramycin in Staphylococcus aureus.金黄色葡萄球菌中23S核糖体RNA的改变及红霉素诱导的对林可霉素和螺旋霉素的耐药性
J Mol Biol. 1973 Feb 15;74(1):67-72. doi: 10.1016/0022-2836(73)90355-0.
5
Translational attenuation: the regulation of bacterial resistance to the macrolide-lincosamide-streptogramin B antibiotics.翻译衰减：细菌对大环内酯-林可酰胺-链阳霉素B类抗生素耐药性的调控
CRC Crit Rev Biochem. 1984;16(2):103-32. doi: 10.3109/10409238409102300.
6
Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.肺炎支原体红霉素耐药菌株23S rRNA中的转换突变
Antimicrob Agents Chemother. 1995 Dec;39(12):2770-3. doi: 10.1128/AAC.39.12.2770.
7
Colicin E3 induced cleavage of 16S ribosomal ribonucleic acid; blocking effects of certain antibiotics.大肠杆菌素E3诱导16S核糖体核糖核酸的切割；某些抗生素的阻断作用。
Biochemistry. 1973 Feb 27;12(5):948-50. doi: 10.1021/bi00729a025.
8
Binding of [14C]erythromycin to Escherichia coli ribosomes.[14C]红霉素与大肠杆菌核糖体的结合
Antimicrob Agents Chemother. 1974 Oct;6(4):474-8. doi: 10.1128/AAC.6.4.474.
9
Ribosomal modification and resistance in antibiotic-producing organisms.抗生素产生菌中的核糖体修饰与抗性
Biochem Soc Symp. 1987;53:1-8.
10
Selective action of erythromycin on initiating ribosomes.红霉素对起始核糖体的选择性作用。
Biochemistry. 1974 Oct 22;13(22):4653-9. doi: 10.1021/bi00719a029.
引用本文的文献
1
Design, development, and validation of new fluorescent strains for studying oral streptococci.用于研究口腔链球菌的新型荧光菌株的设计、开发与验证。
Microbiol Spectr. 2025 Jul 2:e0016825. doi: 10.1128/spectrum.00168-25.
2
Structural studies on ribosomes of differentially macrolide-resistant strains.不同大环内酯耐药菌株核糖体的结构研究
Life Sci Alliance. 2025 Jun 9;8(8). doi: 10.26508/lsa.202503325. Print 2025 Aug.
3
Structural studies of ribosome from an anaerobic Bacteroidetes human pathogen Porphyromonas gingivalis.来自人类厌氧拟杆菌病原体牙龈卟啉单胞菌核糖体的结构研究。
Nucleic Acids Res. 2025 May 22;53(10). doi: 10.1093/nar/gkaf458.
4
Emerging antibiotic resistance by various novel proteins/enzymes.各种新型蛋白质/酶引发的抗生素耐药性不断出现。
Eur J Clin Microbiol Infect Dis. 2025 Apr 15. doi: 10.1007/s10096-025-05126-4.
5
Macrolide resistance in : current insights and future perspectives.大环内酯类耐药性：当前见解与未来展望
JAC Antimicrob Resist. 2025 Apr 2;7(2):dlaf047. doi: 10.1093/jacamr/dlaf047. eCollection 2025 Apr.
6
Beyond antibiotics: exploring multifaceted approaches to combat bacterial resistance in the modern era: a comprehensive review.超越抗生素：探索现代对抗细菌耐药性的多方面方法：全面综述
Front Cell Infect Microbiol. 2025 Mar 18;15:1493915. doi: 10.3389/fcimb.2025.1493915. eCollection 2025.
7
Acquired Bacterial Resistance to Antibiotics and Resistance Genes: From Past to Future.获得性细菌对抗生素的耐药性及耐药基因：从过去到未来
Antibiotics (Basel). 2025 Feb 21;14(3):222. doi: 10.3390/antibiotics14030222.
8
A broad-spectrum lasso peptide antibiotic targeting the bacterial ribosome.一种靶向细菌核糖体的广谱套索肽抗生素。
Nature. 2025 Apr;640(8060):1022-1030. doi: 10.1038/s41586-025-08723-7. Epub 2025 Mar 26.
9
Effects of Antimicrobial Agents Used for Dental Treatments: Impacts on the Human Oral Ecosystem and the Resistome.用于牙科治疗的抗菌剂的作用：对人类口腔生态系统和耐药基因组的影响。
Adv Exp Med Biol. 2025;1472:261-275. doi: 10.1007/978-3-031-79146-8_16.
10
Ribosomes: from conserved origin to functional/medical mobility and heterogeneity.核糖体：从保守起源到功能/医学上的流动性与异质性
Philos Trans R Soc Lond B Biol Sci. 2025 Mar 6;380(1921):20230393. doi: 10.1098/rstb.2023.0393.
本文引用的文献
1
DRUG ANTAGONISM BETWEEN LINCOMYCIN AND ERYTHROMYCIN.林可霉素与红霉素之间的药物拮抗作用。
Science. 1965 Feb 12;147(3659):746-7. doi: 10.1126/science.147.3659.746.
2
ANTIBIOTIC GLYCOSIDES. IV. STUDIES ON THE MECHANISM OF ERYTHROMYCIN RESISTANCE IN BACILLUS SUBTILIS.抗生素糖苷。IV. 枯草芽孢杆菌中红霉素耐药机制的研究。
Proc Natl Acad Sci U S A. 1963 Nov;50(5):955-62. doi: 10.1073/pnas.50.5.955.
3
Similarity in mode of action of chloramphenicol and erythromycin.
Biochim Biophys Acta. 1959 May;33(1):274-5. doi: 10.1016/0006-3002(59)90535-9.
4
The erythromycin group of antibiotics.红霉素类抗生素。
Br Med J. 1957 Jul 13;2(5036):57-63. doi: 10.1136/bmj.2.5036.57.
5
[In vitro antagonism between erythromycin and spiramycin].[红霉素与螺旋霉素的体外拮抗作用]
Ann Inst Pasteur (Paris). 1956 Jun;90(6):787-90.
6
A macrolide-lincosamide-streptogramin B resistance determinant from Bacillus anthracis 590: cloning and expression of ermJ.来自炭疽芽孢杆菌590的大环内酯-林可酰胺-链阳菌素B抗性决定簇：ermJ的克隆与表达
J Gen Microbiol. 1993 Mar;139(3):601-7. doi: 10.1099/00221287-139-3-601.
7
A compilation of large subunit (23S and 23S-like) ribosomal RNA structures: 1993.大亚基（23S及类23S）核糖体RNA结构汇编：1993年。
Nucleic Acids Res. 1993 Jul 1;21(13):3055-74. doi: 10.1093/nar/21.13.3055.
8
Semi-synthetic derivatives of erythromycin.红霉素的半合成衍生物。
Prog Med Chem. 1993;30:57-88. doi: 10.1016/s0079-6468(08)70375-8.
9
Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare.耐克拉霉素胞内分枝杆菌23S rRNA基因中突变的鉴定。
Antimicrob Agents Chemother. 1994 Feb;38(2):381-4. doi: 10.1128/AAC.38.2.381.
10
Molecular characterization of a plasmid-borne (pGT633) erythromycin resistance determinant (ermGT) from Lactobacillus reuteri 100-63.来自罗伊氏乳杆菌100-63的质粒携带（pGT633）红霉素抗性决定簇（ermGT）的分子特征分析
Plasmid. 1994 Jan;31(1):60-71. doi: 10.1006/plas.1994.1007.
Zotero 插件